Navigation Links
Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
Date:1/31/2008

ncome

Taxes 1,426,932 1,158,434 6,730,082 5,648,484

Provision for Income

Taxes(3) 367,602 254,994 1,919,722 1,367,703

Net Income(3) $1,059,330 $903,440 $4,810,360 $4,280,781

Basic Earnings Per

Share(2) $0.79 $0.67 $3.58 $3.18

Average Number of Common

Shares Outstanding During

Each Period - Basic 1,338,559 1,346,087 1,342,552 1,345,386

Diluted Earnings Per

Share(2) $0.78 $0.66 $3.52 $3.14

Average Number of Common

Shares Outstanding During

Each Period - Diluted 1,367,895 1,379,180 1,374,342 1,374,053

See Notes to Results of Operations and Results of Operations -- As Adjusted.

Notes to Results of Operations and Results of Operations -- As Adjusted

(1) Other income, net included royalty income for the 2007 fourth quarter

and full year of $58,351 and $260,399, respectively, compared with

$68,764 and $262,628 for the prior year.

(2) The average number of common shares outstanding for diluted earnings

per share is higher than for basic earnings per share due to the

assumed conversion of the Company's outstanding convertible senior

debentures, outstanding stock options, deferred contingent common

stock awards, performance share awards, restricted stock awards and

convertible preferred stock into common stock equivalents using the

treasury stock method. For purposes of calculating diluted earnings

per share, interest expense, net of capitalized interest and taxes

related to the Company's outstanding convertible senior debentures is

added back to reported net income, and the additional common shares

(assuming conversion) are included in total shares ou
'/>"/>

SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings
2. Wyeth Announces $5 Billion Share Repurchase Program; Declares Increase in Common Stock Dividend
3. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
4. Wyeth Announces Election of New Principal Corporate Officer
5. Wyeth Declares Preferred Stock Dividend
6. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
7. Wyeth Provides Update on Regulatory Review of Viviant (bazedoxifene)
8. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
9. Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals Launch of Generic Pantoprazole in Violation of PROTONIX Patent
10. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... 2 Nearly 600 medical r... funders today convened to explore novel developme... the inaugural Partnering for Cures meeting. ,...the Milken Institute, convened Partnering for Cur...ed to turn a scientific discovery into an accessib...
(Date:12/2/2009)..., Gabon, December 2 , - "...lem and Heritage" , Coinciding with the I...he,Gabonese Republic is hosting an international c...feguarding biological resources in Africa. The,con...eaders, ministers,scientific experts, private com...
(Date:12/2/2009)..., Dec. 2 S*BIO Pte Ltd today annou...ibitor, SB1518, at The American Society of Hematol...ans. ,, Data will be presented on the clinical ...SB1518 detailing its safety, tolerability and phar...e levels ranging from 100 to 600 mg. These doses w...
(Date:12/2/2009)..., Dec. 2 /PRNewswire-Asia/ -- The world is going t... and uncertainty is part of many,businesses and in...s been,relatively immune to the economic downturn,... During the midst of the difficult times this ye... inaugurated an R&D center in Shanghai, the la...
Breaking Biology Technology:Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
...e quantities of difficult-to-express proteins ,...iochemical & Molecular Allergology, Research Cente...odonPlus(DE3)-RIL cells * with,extra copies of E...ossible to attain high-level expression of difficu...nduced expression of several recombinant peanut al...
...RoboCycler Gradient 96 temperature cycler ,,.... , Stratagenes RoboCycler Gradient 96 tempera...ed to perform fluorescent-tag cycle,sequencing u...ing,ready reaction kit. The new Hot Top Assembly...ays that hinder the loading of cycle sequencing re...
...,, Achieve superior transfection efficiencie...cott Basehore Jeff Braman ,Stratagene , Plasm...,EF plasmid midiprep kit, a kit based on anion e...um chloride density gradient centrifugation. Plasm...-nm optical density ratios) were comparable,with...
Other Biology Technology:High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 2High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 3High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 4Automated Fluorescent-Tag Cycle Sequencing 2Automated Fluorescent-Tag Cycle Sequencing 3Automated Fluorescent-Tag Cycle Sequencing 4Automated Fluorescent-Tag Cycle Sequencing 5Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell,Line 2Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell,Line 3Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell,Line 4
(Date:12/3/2009)...design of the upcoming forest deal at Copenhagen i...to a scientist at the University of Leeds. , Wr...t at least 50% of the carbon credit payments to be...ssions from Deforestation and Degredation), should...operty rights assured. , "There is the potential...
(Date:12/3/2009)... U.S. Department of Energy,s (DOE) Brookhaven Nati...n Institute of Science has made a major step in un...mation in DNA that is necessary to carry out impor... in the December 1, 2009 edition of Nature Struct...eins responsible for interacting at specific sites...
(Date:12/2/2009)...no men have a more difficult time quitting smoking...ure, but acculturation has no affect on Latinas od...are published in Cancer Epidemiology, Biomarkers ...on for Cancer Research. The December issue has a s...s smoking cessation differently for Latino men and...
Breaking Biology News(10 mins):Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Grooving down the helix 2Grooving down the helix 3Acculturation affects smoking cessation success among Latinos 2A Pets Bite Can Pass on MRSA 49599 1A Pets Bite Can Pass on MRSA 49599 2Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 1Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 2Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 3Spinal Cancer Patient Finds New Hope at the Palo Alto Medical Foundation 49594 4HealthLeaders InterStudy Unveils Enhanced Employer Vantage 49589 1HealthLeaders InterStudy Unveils Enhanced Employer Vantage 49589 2
... desperately try to reach for a break in the canop... affliction: Shade avoidance syndrome or SAS. Now,... light by researchers at the Salk Institute for Bi...rs shade, plants switch on a natural chemical fact...auxin that lets a plant grow and ultimately stretc...
...the inaugural conference of the iPlant Collaborati... virtual center in cyberspace for plant sciences r...itled "Bringing Plant and Computing Scientists Tog...nd scheduled for April 7-9, 2008, will take the fi...test unsolved mysteries its grand challenge quest...
... Society of Agronomy (ASA), Crop Science Society o...ica (SSSA) recognize the following undergraduate s... National Student Recognition Program announced in...ine. , The 2008 National Student Recognition Prog...s enrolled in agronomy, crop, soil, or environment...
Other Biology News:A place in the sun 2A place in the sun 3iPlant Kickoff Conference at CSHL begins tackling plant biology's grand challenges 2iPlant Kickoff Conference at CSHL begins tackling plant biology's grand challenges 3Outstanding undergraduates recognized in agronomy, crop, soil, and environmental sciences 2
...noCortin (POMC) has long been a molecule of fascin... of biologically-active peptides such as ACTH, -Li...mulating Hormone (a-MSH) and more. It is also a ve...rtebrates studied, including those "living fossils...
Mouse Anti-Rat Pan-NMDA NR1 Monoclonal Antibody, Unconjugated, Clone R1JHL from Calbiochem
BRASMC (B950-05) from European Collection of Cell Cultures (ECACC)
T4 DNA Ligase from Promega
Biology Products: